Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Tinea; Tinea Pedis | Phase 1 | ClinicalTrials |
| HIV Infections | Phase 4 | ClinicalTrials |
| Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting | Phase 1 | ClinicalTrials |
| Hemorrhage | Phase 3 | ClinicalTrials |
| Osteoarthritis | Early Phase 1 | ClinicalTrials |
| Coinfection; Hepatitis B | Phase 3 | ClinicalTrials |
| Communicable Diseases; Hemorrhagic Fever, Ebola; Infection; Virus Diseases | Phase 1/Phase 2 | ClinicalTrials |
| Infection | Phase 3 | ClinicalTrials |
| Coinfection; Hepatitis; Hepatitis B | Phase 4 | ClinicalTrials |
| Gastroparesis | Phase 1 | ClinicalTrials |
| Malaria, Vivax | Phase 1 | ClinicalTrials |
CONTENTS